MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字H20253610

March 11, 2025

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂

按C₁₃H₂₁NO₃计 3ml:0.31mg

化学药品

March 11, 2025

Company Information

Applicant Company

山西省大同经济技术开发区医药工业园区二园区通源街909号

Manufacturing Company

山西省大同市阳高西北街6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath